Search research articles
Contact Us
Filters
Showing results (21-30 of 121) with videos related to
Page
of 13
Sort By:
Cancer
|
June 29, 2006
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer
M Dror Michaelson, Donald S Kaufman, Philip Kantoff, et al.
Clinical Genitourinary Cancer
|
September 18, 2016
Heterogeneity of Patients With Intermediate-Prognosis Metastatic Renal Cell Carcinoma Treated With Sunitinib
Avishay Sella, M Dror Michaelson, Ewa Matczak, et al.
Plos One
|
August 30, 2019
Treatment sequences for advanced renal cell carcinoma: A health economic assessment
Baris Deniz, Apoorva Ambavane, Shuo Yang, et al.
The New England Journal of Medicine
|
September 15, 2006
Case records of the Massachusetts General Hospital. Case 28-2006. A 59-year-old man with masses in both kidneys
W Scott McDougal, Nina E Tolkoff-Rubin, M Dror Michaelson, et al.
The Journal of Urology
|
April 20, 2010
Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer
Philip J Saylor, Donald S Kaufman, M Dror Michaelson, et al.
Academic Radiology
|
March 16, 2005
Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1)
Cedric De Bazelaire, Neil M Rofsky, Guillaume Duhamel, et al.
The New England Journal of Medicine
|
May 30, 2008
Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma
M Dror Michaelson, Othon Iliopoulos, David F McDermott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2012
Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer
Philip J Saylor, Umar Mahmood, Anchisa Kunawudhi, et al.
Plos One
|
August 31, 2018
Application of dynamic modeling for survival estimation in advanced renal cell carcinoma
Baris Deniz, Arman Altincatal, Apoorva Ambavane, et al.
CA: a Cancer Journal for Clinicians
|
May 27, 2008
Management of complications of prostate cancer treatment
M Dror Michaelson, Shane E Cotter, Patricio C Gargollo, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 121) with videos related to
Sort By:
Page
of 13
Cancer
|
June 29, 2006
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer
M Dror Michaelson, Donald S Kaufman, Philip Kantoff, et al.
Clinical Genitourinary Cancer
|
September 18, 2016
Heterogeneity of Patients With Intermediate-Prognosis Metastatic Renal Cell Carcinoma Treated With Sunitinib
Avishay Sella, M Dror Michaelson, Ewa Matczak, et al.
Plos One
|
August 30, 2019
Treatment sequences for advanced renal cell carcinoma: A health economic assessment
Baris Deniz, Apoorva Ambavane, Shuo Yang, et al.
The New England Journal of Medicine
|
September 15, 2006
Case records of the Massachusetts General Hospital. Case 28-2006. A 59-year-old man with masses in both kidneys
W Scott McDougal, Nina E Tolkoff-Rubin, M Dror Michaelson, et al.
The Journal of Urology
|
April 20, 2010
Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer
Philip J Saylor, Donald S Kaufman, M Dror Michaelson, et al.
Academic Radiology
|
March 16, 2005
Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1)
Cedric De Bazelaire, Neil M Rofsky, Guillaume Duhamel, et al.
The New England Journal of Medicine
|
May 30, 2008
Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma
M Dror Michaelson, Othon Iliopoulos, David F McDermott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2012
Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer
Philip J Saylor, Umar Mahmood, Anchisa Kunawudhi, et al.
Plos One
|
August 31, 2018
Application of dynamic modeling for survival estimation in advanced renal cell carcinoma
Baris Deniz, Arman Altincatal, Apoorva Ambavane, et al.
CA: a Cancer Journal for Clinicians
|
May 27, 2008
Management of complications of prostate cancer treatment
M Dror Michaelson, Shane E Cotter, Patricio C Gargollo, et al.
Page
of 13